ACADIA Pharmaceuticals Inc. 5,750,000 Shares Common Stock UNDERWRITING AGREEMENT dated April 4, 2007 Banc of America Securities LLC Lehman Brothers Inc. Deutsche Bank Securities Inc. Piper Jaffray & Co. JMP Securities LLC Rodman & Renshaw, LLCUnderwriting Agreement • April 5th, 2007 • Acadia Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledApril 5th, 2007 Company Industry JurisdictionThe lock-up restriction described in the previous paragraph shall not apply to: (1) bona fide gifts to, or transfers to a trust for, the direct or indirect benefit of the undersigned or the immediate family of the undersigned, (2) any shares of Common Stock sold pursuant to any 10b5-1 plan existing on or prior to the date hereof, and (3) the entering into a 10b5-1 plan during the Lock-Up Period so long as no shares of Common Stock are sold pursuant to such 10b5-1 plan during the Lock-Up Period; provided that in any transaction described in clause (1) above, (x) prior to such donation, transfer or distribution, such donee, transferee, or distributee shall execute and deliver to the Representatives a duplicate form of this lock-up agreement and (y) the undersigned shall not be required to, and shall not voluntarily, file a report under Section 16(a) of the Exchange Act. For purposes of this lock-up agreement, “immediate family” shall mean any relationship by blood, marriage or adoption,
GeoMet, Inc. Common Stock UNDERWRITING AGREEMENT dated July 27, 2006 Banc of America Securities LLC A.G. Edwards & Sons, Inc. Raymond James & Associates, Inc.Underwriting Agreement • August 10th, 2006 • GeoMet, Inc. • Crude petroleum & natural gas • New York
Contract Type FiledAugust 10th, 2006 Company Industry JurisdictionStandards No. 69 (November 1982) of the FASB and Rules 4–10(a) (1)–(13) of Regulation S–X and Rule 302(b) of Regulation S–K of the SEC; provided, however, that (i) certain estimated data have not been provided with respect to changes in reserves information and (ii) future income tax expenses have not been taken into account in estimating the future net revenue and present worth values set forth in the Reserves Report.